Comparable Inflammatory and Metabolic Outcomes after Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study) - Serrano-Villar,S.; Martín-Pedraza,L.; Tiraboschi,J.; Novella,M.; Cabello-Úbeda,A.; López-Cortés,L.; Busca,C.; Torralba,M.; Crusells,M.J.; Hidalgo-Tenorio,C.; Estrada,V.; Del Amo-De Palacios,A.; et al. (Clinical Infectious Diseases, 2026)